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The phosphorylation of a tyrosine substrate is one of the most crucial reactions that regulate numerous
biological processes. The phosphorylation is controlled by protein tyrosine kinases (PTKs) and protein
tyrosine phosphatases (PTPs). Malfunctions of either class of enzymes resulted in pathological diseases.
Despite an equal importance of both classes of enzymes, the development of PTK inhibitors is advanced,
while that of PTPs is lagging. Therefore, we provide a mini-review of inhibitors of protein tyrosine
phosphatase 1B (PTP1B), an enzyme in PTP superfamily, aiming to gain an attention to the development
of PTP inhibitors. PTP1B is a PTP that has been fully characterized and proved as a drug target for type 2
diabetes and obesity treatment. In the past few decades, the development of effective PTP1B inhibitors by
pharmaceutical industries has been unsuccessful and remained challenging due to the difficulty in
balancing drug properties, i.e. potency, selectivity, and cell permeability of the inhibitors. In this dissertation,
we present a novel strategy called “exo-affinity-labeling” to modulate PTP1B activity. The exo-affinity labeling
agent covalently inhibits PTP1B in a unique way and this, so called, inactivator might be able to provide the
desired drug properties. We report a series of inhibitors of PTP1B. A short-linker TDZ 8a and long-linker
TDZs 11a, and 11b exhibit time- and concentration-dependent loss of PTP1B activity. Mass spectrometry
analysis shows that 8a covalently modifies Cys121. However, the inactivation reaction is second-order with
the rate constant (kinact) of 168 ± 25 M-1min-1 and we did not observe saturation kinetics in a re-plot of
observed pseudo-first order rate constant (kobs) versus concentrations. This suggests that the inactivation
by 8a is not an affinity-labeling agent. The absence of the saturation kinetics is also observed in the
inactivation by 11a. On the other hand, 11b is the only inactivator that exhibits the saturation kinetics,
suggesting the affinity-labeling mechanism. Fitting a curve to a hyperbolic equation for affinity-labeling
agent gives a rate constant (kinact) of 4.7 ± 0.6 x 102 M-1min-1 and a dissociation constant (KI) = 17±4
?M. However, further study is needed to reveal an insight of the inactivation mechanism.
